LFB is a pharmaceutical group specialising in medicinal products derived from living organisms
Medicinal products sold in almost 60 countries
LFB has a special place in France, as a player in the healthcare industry with a public health mission
A public company active in a competitive market
23 hospital-prescribed medicinal products
LFB provides bioproduction services
Patient safety, a top priority for LFB
There are several medicinal products at an advanced stage of development, for registration in Europe and the USA
Information on clinical trials currently being conducted by LFB
Two proprietary platforms for therapeutic and technological innovation
Innovations to constantly improve the biosafety of medicinal products
A highly qualified Scientific Board developing new biotherapeutics
LFB has a continuing commitment to social issues, offering several therapeutic solutions, both currently on sale and under development, for rare diseases
LFB is a partner in several patients’ associations and supports projects focused on a better quality of life for patients and their families
LFB’s ethical commitment is reflected in the way it exercises its environmental, social and economic responsibilities
Transparency of interests for France
marketed in almost
Home › Products and activities › Services
LFB draws on its pharmaceutical and industrial expertise and know-how to develop its offering of bioproduction services.
Some LFB group companies offer bioproduction services in the fields of plasma-derived medicinal products as biotechnology.
LFB is carrying out technology transfer with governments or public corporations in the field of plasma-derived medicinal products.